The Italian Supreme Court (Ruling 8224/25) recently made a major decision regarding who is responsible when a vaccine, specifically the flu shot Fluarix, causes serious health problems.
The Story Behind the Case
A patient received the Fluarix vaccine (made by GlaxoSmithKline) and later developed a severe brain/spinal cord inflammation called encephalomyelitis. The patient sued the pharmaceutical company for damages, claiming the vaccine was the cause.
Ermes (anfora attica 490 AC ca)
The Legal “Muddle”
Initially, the lower courts ruled in favor of the patient. However, they made a mistake that the Supreme Court had to fix: they mixed up two different sets of laws to reach their verdict.
- The “Defective Product” Law: This says a company is responsible if their product isn’t as safe as a person would reasonably expect.
- The “Dangerous Activity” Law: This says that because making medicine is inherently “dangerous,” the company is almost always responsible unless they can prove they did everything humanly possible to prevent harm.
The lower courts essentially created a “hybrid” version of these two laws, which the Supreme Court said was unfair and legally incorrect.
What the Supreme Court Decided
The Supreme Court didn’t say the patient was wrong, but they said the legal reasoning used to punish the company was flawed. Here are the main takeaways:
- You can’t mix and match: A judge must pick one legal “path” and stick to it. They cannot take the harshest parts of one law and combine them with another to make it impossible for a company to defend itself.
- “Dangerous” is not the same as “Defective”: Just because a vaccine is powerful and carries some inherent risks (dangerous activity), it doesn’t automatically mean the specific bottle or formula was “defective.”
- The “Science Defense”: Under the product liability law, if a company can prove that—at the time the vaccine was sold—even the best scientists in the world didn’t know about a specific side effect, they might not be held responsible for a “defect.”
What Happens Now?
The case isn’t over. The Supreme Court ordered a retrial. The new judges must now look at the facts again, but this time they must pick one clear legal rule and apply it correctly without “blending” the laws together.
In short: This ruling protects companies from being held to an impossible standard where they are blamed for risks that science hadn’t even discovered yet, while still allowing patients to sue—provided the correct legal path is followed.
